235 related articles for article (PubMed ID: 36645078)
1. Heart-Brain Team Approach of Acute Myocardial Infarction Complicating Acute Stroke: Characteristics of Guideline-Recommended Coronary Revascularization and Antithrombotic Therapy and Cardiovascular and Bleeding Outcomes.
Suzuki T; Kataoka Y; Shiozawa M; Morris K; Kiyoshige E; Nishimura K; Murai K; Sawada K; Iwai T; Matama H; Honda S; Fujino M; Yoneda S; Takagi K; Otsuka F; Asaumi Y; Koga M; Ihara M; Toyoda K; Tsujita K; Noguchi T
J Am Heart Assoc; 2023 Jan; 12(2):e027156. PubMed ID: 36645078
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and bleeding risks of inactive cancer in patients with acute myocardial infarction who received primary percutaneous coronary intervention using drug-eluting stent and dual/triple antithrombotic therapy.
Hayashi H; Kataoka Y; Murai K; Sawada K; Iwai T; Matama H; Honda S; Fujino M; Yoneda S; Takagi K; Otsuka F; Asaumi Y; Izumiya Y; Fukuda D; Noguchi T
Cardiovasc Diagn Ther; 2022 Dec; 12(6):803-814. PubMed ID: 36605075
[TBL] [Abstract][Full Text] [Related]
3. Rationale, Design, and Baseline Characteristics of the Prospective Japan Acute Myocardial Infarction Registry (JAMIR).
Honda S; Nishihira K; Kojima S; Takegami M; Asaumi Y; Suzuki M; Kosuge M; Takahashi J; Sakata Y; Takayama M; Sumiyoshi T; Ogawa H; Kimura K; Yasuda S;
Cardiovasc Drugs Ther; 2019 Feb; 33(1):97-103. PubMed ID: 30470946
[TBL] [Abstract][Full Text] [Related]
4. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?
Mamas MA; Ratib K; Routledge H; Neyses L; Fraser DG; de Belder M; Ludman PF; Nolan J;
JACC Cardiovasc Interv; 2013 Jul; 6(7):698-706. PubMed ID: 23769648
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Impact of Polyvascular Disease in Patients With Acute Myocardial Infarction in the Contemporary Era of Percutaneous Coronary Intervention - Insights From the Japan Acute Myocardial Infarction Registry (JAMIR).
Arai R; Okumura Y; Murata N; Fukamachi D; Honda S; Nishihira K; Kojima S; Takegami M; Asaumi Y; Yamashita J; Saji M; Hibi K; Takahashi J; Sakata Y; Takayama M; Sumiyoshi T; Ogawa H; Kimura K; Yasuda S;
Circ J; 2024 May; 88(6):911-920. PubMed ID: 38008436
[TBL] [Abstract][Full Text] [Related]
6. Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study.
Lamberts M; Olesen JB; Ruwald MH; Hansen CM; Karasoy D; Kristensen SL; Køber L; Torp-Pedersen C; Gislason GH; Hansen ML
Circulation; 2012 Sep; 126(10):1185-93. PubMed ID: 22869839
[TBL] [Abstract][Full Text] [Related]
7. Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
Saltzman AJ; Stone GW; Claessen BE; Narula A; Leon-Reyes S; Weisz G; Brodie B; Witzenbichler B; Guagliumi G; Kornowski R; Dudek D; Metzger DC; Lansky AJ; Nikolsky E; Dangas GD; Mehran R
JACC Cardiovasc Interv; 2011 Sep; 4(9):1011-9. PubMed ID: 21939942
[TBL] [Abstract][Full Text] [Related]
8. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
[TBL] [Abstract][Full Text] [Related]
9. Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
Koskinas KC; Räber L; Zanchin T; Pilgrim T; Stortecky S; Hunziker L; Blöchlinger S; Billinger M; Gartwyl F; Moro C; Moschovitis A; Jüni P; Heg D; Windecker S
JACC Cardiovasc Interv; 2016 Jul; 9(14):1473-83. PubMed ID: 27478115
[TBL] [Abstract][Full Text] [Related]
10. Ticagrelor versus clopidogrel in acute myocardial infarction patients with multivessel disease; From Korea Acute Myocardial Infarction Registry-National Institute of Health.
Ahn JH; Ahn Y; Jeong MH; Kim JH; Hong YJ; Sim DS; Kim MC; Hwang JY; Yoon JH; Seong IW; Hur SH; Oh SK;
J Cardiol; 2020 May; 75(5):478-484. PubMed ID: 31859138
[TBL] [Abstract][Full Text] [Related]
11. In-Hospital Outcomes of Acute Myocardial Infarction With Essential Thrombocythemia and Polycythemia Vera: Insights From the National Inpatient Sample.
Wu J; Fan Y; Zhao W; Li B; Pan N; Lou Z; Zhang M
J Am Heart Assoc; 2022 Dec; 11(24):e027352. PubMed ID: 36515250
[TBL] [Abstract][Full Text] [Related]
12. Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy).
Kirtane AJ; Sandhu P; Mehran R; McEntegart M; Cristea E; Brener SJ; Xu K; Fahy M; Généreux P; Wessler JD; Stone GW
Am J Cardiol; 2014 Jan; 113(1):36-43. PubMed ID: 24169019
[TBL] [Abstract][Full Text] [Related]
13. Cilostazol-based triple versus potent P2Y12 inhibitor-based dual antiplatelet therapy in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Kim W; Kim JS; Rha SW; Choi BG; Jang WY; Kang DO; Park Y; Choi JY; Roh SY; Na JO; Choi CU; Kim EJ; Park CG; Seo HS; Choi SY; Byun JK; Cha J; Oh DJ; Jeong MH;
Heart Vessels; 2020 Sep; 35(9):1181-1192. PubMed ID: 32270356
[TBL] [Abstract][Full Text] [Related]
14. Predictive models for adverse clinical outcomes in Chinese patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting.
Zheng JY; Cao Y; Li DT; Qiu YG; Zhao L; Xu ZM; Huang YX; Hong ZB; Li TC; Tang YD; Guo CJ; Ma ZM; Wu YQ; Chen Y
Acta Cardiol; 2022 Jun; 77(4):360-365. PubMed ID: 34353224
[TBL] [Abstract][Full Text] [Related]
15. Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial.
Kim CJ; Park MW; Kim MC; Choo EH; Hwang BH; Lee KY; Choi YS; Kim HY; Yoo KD; Jeon DS; Shin ES; Jeong YH; Seung KB; Jeong MH; Yim HW; Ahn Y; Chang K;
Lancet; 2021 Oct; 398(10308):1305-1316. PubMed ID: 34627490
[TBL] [Abstract][Full Text] [Related]
16. Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.
Hess CN; Peterson ED; Peng SA; de Lemos JA; Fosbol EL; Thomas L; Bhatt DL; Saucedo JF; Wang TY
J Am Coll Cardiol; 2015 Aug; 66(6):616-27. PubMed ID: 26248987
[TBL] [Abstract][Full Text] [Related]
17. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.
Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW
Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052
[TBL] [Abstract][Full Text] [Related]
18. [Related factors and the long-term outcome after percutaneous coronary intervention of premature acute myocardial infarction].
Xu JJ; Jiang L; Song Y; Yao Y; Jia SD; Liu Y; Yuan DS; Li TY; Chen J; Wu Y; Zhang J; Chen JL; Yang YJ; Gao RL; Qiao SB; Xu B; Yuan JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug; 48(8):655-660. PubMed ID: 32847321
[No Abstract] [Full Text] [Related]
19. The Prognostic Impact of In-Hospital Major Bleeding and Recurrence of Myocardial Infarction during Acute Phase after Percutaneous Coronary Intervention for Acute Myocardial Infarction.
Matsuoka Y; Sotomi Y; Hikoso S; Nakatani D; Okada K; Dohi T; Kida H; Oeun B; Sunaga A; Sato T; Kitamura T; Sakata Y; Sato H; Hori M; Komuro I; Sakata Y
J Atheroscler Thromb; 2024 Feb; 31(2):158-170. PubMed ID: 37599086
[TBL] [Abstract][Full Text] [Related]
20. [Risk of fatal/non-fatal events in patients with previous coronary heart disease/acute myocardial infarction and treatment with non-steroidal anti-inflammatory drugs].
Muñoz Olmo L; Juan Armas J; Gomariz García JJ
Semergen; 2018; 44(5):355-363. PubMed ID: 28882733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
